Pharmaceutical packaging, one of the most innovative sectors in Italy, plays a key role in ensuring product integrity, traceability and compliance with EU regulatory requirements. The ability to trace the path of a medicine along the entire distribution chain is essential to prevent counterfeiting, which not only harms manufacturers but also compromises patient safety. This mechanism is also indispensable for…
Centrality of the individual, sustainability and resilience. These are the pivotal points identified by the European Union for the development of Industry 5.0, a manufacturing paradigm more focused on the well-being of the individual, society and the Planet. The factory of the future, according to the EU's vision, will be increasingly smart. It will harness the potential offered by technological…
Biological medicines are products derived from living organisms, used in the treatment of serious diseases such as diabetes, cancer, and autoimmune diseases. The active ingredients in these medicines are more complex, compared to non-biological products, so they require much more development time and cost, which limits patients' access to treatment. Biosimilar medicines, which have been used in the European Union…
Innovation Impact - Effects, Impact and Future of Technological Innovation, the study conducted by Ipsos on behalf of the Rome Chamber of Commerce, was presented on October 13. Conducted on a sample of 4,000 people, in Italy, France, Germany and the United States, the research analysed the impact of new technologies in different areas through the participants' perceptions. According to…
Non-prescription medications contain widely used active ingredients and dosages of low toxicity, intended to treat mild, transient ailments that are very common during the change of seasons. These medicines have years of research and large case histories of use behind them, are periodically monitored by the Ministry of Health, and usually do not give rise to complex side effects. Assessment…
Despite difficulties in supplies and the rising cost of raw materials, the Italian pharmaceutical industry still grew in 2022. Production was up 10 percent, with a total value of 38 billion euros and a 44 percent increase in exports. Signs that confirm the excellence of the Italian pharmaceutical supply chain, first in Europe with results that far exceed the main…
Health and sustainability are closely related issues, involving environmental, economic and social aspects. Among the main challenges facing the Pharma and Healthcare sector today is undoubtedly the need to accelerate the green transition: a priority for institutional agendas, but also for new consumer groups, which are increasingly inclined to buy eco-friendly products. The EU's global strategy, in addition to reaffirming…
Digital natives, by definition, are close relatives to technological innovation. This familiarity is considered an added value by many companies, which decide to invest in the re-skilling and training of new resources by focusing precisely on younger people. To develop new skills and create figures capable of dealing with advanced production processes and increasingly sophisticated machinery. The signs of change…
The pharma sector is a strategic high-innovation sector, which in recent years has shown that it can create development and provide skilled labour. Today, to work in the pharmaceutical industry, new knowledge and skills are needed that can support the digital transition and meet 4.0 standards. This transformation is already bringing significant benefits in terms of production, exports, sustainability, retraining…
The evolution of industrial automation processes, with the introduction of digitalisation systems and the transition to Industry 4.0, is slowly redefining our economy, with a positive impact in terms of efficiency and sustainability. A recent survey carried out by ANIE Automazione, a company representing automation technology suppliers in Italy, shows that the first quarter of 2022 ended positively for 94%…
